Medical Device Company MLM Biologics Graduates from UF Innovate | Sid Martin Biotech Program

The company is commercializing its FDA-cleared bio-ConneKt® Wound
Matrix to the advance wound care market.

ALACHUA, Fla.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/MLMBiologics?src=hash" target="_blank"gt;#MLMBiologicslt;/agt;–UF
Innovate | Sid Martin Biotech, the leading biotechnology
incubator at the University of Florida, is pleased to announce that
resident company MLM
Biologics, Inc. has graduated from its program. MLM Biologics is a
medical device company that provides evidence-based solutions in the
advance wound care and musculoskeletal clinical spaces. The company
designs, develops, manufactures and commercializes clinical products
that are aimed to offer the best medical-economic alternatives in those
markets. The company is currently commercializing its flagship product,
the FDA-cleared, bio-ConneKt®
Wound Matrix, in the advance wound care market. Having successfully
obtained requisite clearances for use across civilian, military and VA
clinical spaces, MLM will be graduating into a stand-alone commercial
space in Gainesville’s Innovation District to expand their manufacturing
capabilities.

“Retaining a high growth company like MLM Biologics in Alachua County
and in the State is a big win for our economy. MLM Biologics will
continue to expand their operations and bring investments and jobs into
our community,” said Merrie Shaw, Assistant Director of UF Innovate |
Sid Martin Biotech. The company was able to locate their headquarters
locally due to the availability of suitable, specialized commercial
space, which is not readily available in many other communities.

MLM Biologics joins more than 60 biotech company alumni of Sid Martin
Biotech, including AxoGen
(NASDAQ: AXGN), Applied
Genetic Technologies Corporation (NASDAQ: AGTC), RTI
Surgical (NASDAQ: RTIX), Ology
Bioservices and Captozyme.

“As a start-up, we faced an unexpected, abrupt change in our business
plan. Sid Martin Biotech provided a soft landing and the platform for us
to mature as a commercial entity. With the core of MLM fueled locally,
we are especially pleased to continue our growth and expansion here,”
said Chandra
Nataraj, CEO & Co-Founder of MLM Biologics.

Mark
Long, Director of UF Incubation Services, stated, “This is a great
example of UF Innovate’s role in economic development in Gainesville –
we support startup companies so they can graduate and occupy space
locally, adding jobs and revenues to the local and state economy.”

About MLM Biologics

MLM Biologics is a Florida-based startup company focused on delivering
clinically and cost-effective medical solutions to serve the needs of
patients worldwide. The company has developed a proprietary platform
technology that enables design and manufacture of clinically useful
biologic products across a wide range of medical specialties. MLM
Biologics, an ISO-13485 compliant company, is currently commercializing
the bio-ConneKt® Wound Matrix, an FDA-cleared medical device for
clinically managing a variety of chronic, acute, traumatic and burn
wounds. The bio-ConneKt® Wound Matrix is helping change wound care
management from the traditional “low tech, high touch” approach to a
“high tech, low touch” paradigm that benefits all stakeholders in the
wound care space. For more information, visit MLM
Biologics.

About UF Innovate | Sid Martin Biotech

UF Innovate | Sid Martin Biotech is the leading biotechnology incubator
headquartered at the University of Florida in Alachua, Florida, at
Progress Park. Sid Martin has been honored with national and
international awards for incubator excellence and achievements in
technology commercialization, funding access, job creation and
technology-based economic development. It is dedicated to mentoring and
accelerating the growth of innovative early-stage bioscience and
biotechnology companies and supporting the economic growth of the North
Central Florida region. For more information, visit Sid
Martin Biotech.

Contacts

Company Contact:
MLM Biologics, Inc.
Chandra Nataraj,
PhD, DVM
CEO & CTO
[email protected]
http://mlmbiologics.com/
Sid
Martin Biotech Contact:
UF Innovate | Sid Martin Biotech
Merrie
Shaw
Assistant Director
[email protected]
http://innovate.research.ufl.edu/sid-martin-biotech/